Lawrence Biegelsen
Stock Analyst at Wells Fargo
(1.48)
# 3,250
Out of 4,840 analysts
50
Total ratings
54.84%
Success rate
-5.37%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lawrence Biegelsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABT Abbott Laboratories | Maintains: Overweight | $136 → $147 | $131.30 | +11.96% | 5 | Apr 17, 2025 | |
| PODD Insulet | Maintains: Overweight | $305 → $322 | $321.50 | +0.16% | 4 | Feb 21, 2025 | |
| NPCE NeuroPace | Upgrades: Overweight | $16 → $20 | $17.68 | +13.12% | 7 | Mar 14, 2024 | |
| TNDM Tandem Diabetes Care | Maintains: Overweight | $166 → $82 | $20.72 | +295.75% | 5 | Aug 4, 2022 | |
| TFX Teleflex | Downgrades: Equal-Weight | $248 | $120.78 | +105.33% | 1 | Jul 29, 2022 | |
| BDX Becton, Dickinson and Company | Upgrades: Overweight | $275 | $171.38 | +60.46% | 4 | Jun 24, 2022 | |
| ISRG Intuitive Surgical | Maintains: Overweight | $350 → $339 | $539.54 | -37.17% | 2 | Apr 22, 2022 | |
| REE REE Automotive | Initiates: Underweight | $1.5 | $0.85 | +76.72% | 1 | Mar 25, 2022 | |
| LUNG Pulmonx | Maintains: Equal-Weight | $55 → $27 | $3.11 | +768.17% | 3 | Feb 24, 2022 | |
| ZBH Zimmer Biomet Holdings | Maintains: Underweight | $124 → $111 | $92.64 | +19.82% | 2 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $144 | $84.51 | +70.10% | 1 | Jan 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $56 | $96.02 | -41.68% | 4 | Jan 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $68 → $74 | $95.38 | -22.42% | 6 | Oct 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $77 | $74.99 | +2.24% | 3 | Apr 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $85 → $90 | $18.54 | +385.44% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | n/a | $58.96 | - | 1 | Dec 12, 2019 |
Abbott Laboratories
Apr 17, 2025
Maintains: Overweight
Price Target: $136 → $147
Current: $131.30
Upside: +11.96%
Insulet
Feb 21, 2025
Maintains: Overweight
Price Target: $305 → $322
Current: $321.50
Upside: +0.16%
NeuroPace
Mar 14, 2024
Upgrades: Overweight
Price Target: $16 → $20
Current: $17.68
Upside: +13.12%
Tandem Diabetes Care
Aug 4, 2022
Maintains: Overweight
Price Target: $166 → $82
Current: $20.72
Upside: +295.75%
Teleflex
Jul 29, 2022
Downgrades: Equal-Weight
Price Target: $248
Current: $120.78
Upside: +105.33%
Becton, Dickinson and Company
Jun 24, 2022
Upgrades: Overweight
Price Target: $275
Current: $171.38
Upside: +60.46%
Intuitive Surgical
Apr 22, 2022
Maintains: Overweight
Price Target: $350 → $339
Current: $539.54
Upside: -37.17%
REE Automotive
Mar 25, 2022
Initiates: Underweight
Price Target: $1.5
Current: $0.85
Upside: +76.72%
Pulmonx
Feb 24, 2022
Maintains: Equal-Weight
Price Target: $55 → $27
Current: $3.11
Upside: +768.17%
Zimmer Biomet Holdings
Feb 8, 2022
Maintains: Underweight
Price Target: $124 → $111
Current: $92.64
Upside: +19.82%
Jan 19, 2022
Upgrades: Overweight
Price Target: $144
Current: $84.51
Upside: +70.10%
Jan 19, 2022
Upgrades: Equal-Weight
Price Target: $56
Current: $96.02
Upside: -41.68%
Oct 29, 2021
Maintains: Equal-Weight
Price Target: $68 → $74
Current: $95.38
Upside: -22.42%
Apr 28, 2020
Downgrades: Equal-Weight
Price Target: $77
Current: $74.99
Upside: +2.24%
Mar 5, 2020
Upgrades: Overweight
Price Target: $85 → $90
Current: $18.54
Upside: +385.44%
Dec 12, 2019
Upgrades: Overweight
Price Target: n/a
Current: $58.96
Upside: -